Completed PHASE4 INTERVENTIONAL 2-arm NCT04802122

Induction of Anesthesia With Sevoflurane Preserving Spontaneous Breathing: Cardiorespiratory Effects.

Comparative Assessment of Intubating Conditions and Cardiorespiratory Effects of Sevoflurane Induction and Intubation.

Sponsor: Aristotle University Of Thessaloniki

Conditions Anesthesia Intubation Complication Cardiovascular Complication Intubation

Interventions Propofol Fresenius Sevoflurane inhalant product

Updated 5 times since 2021 Last updated: Aug 2, 2021 Started: May 24, 2021 Primary completion: Jul 13, 2021 Completion: Jul 14, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Anesthesia Intubation Complication and Cardiovascular Complication, this trial is completed. The trial is conducted by Aristotle University Of Thessaloniki and has accumulated 5 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2021 — Jul 2024 [monthly]

Completed PHASE4

Status: Not Yet Recruiting → Completed
May 2021 — Sep 2021 [monthly]

Not Yet Recruiting PHASE4
Apr 2021 — May 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aristotle University Of Thessaloniki

Data source: Aristotle University Of Thessaloniki

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Thessaloniki, Greece